Provider: BehaviorLive — via AVBCC
Take This Course →Including ethics, supervision, and topics like this one. New live CEU every Wednesday.
Join Free →As the healthcare industry continues to shift toward value-based care models, stakeholders are exploring innovative ways to align financial incentives with improved patient outcomes. One emerging area of focus is the integration of the federal 340B Drug Pricing Program into value-based arrangements between manufacturers, payors, healthcare providers, employer groups, and other stakeholders. This panel will explore how 340B program participation can be strategically and compliantly leveraged within value-based frameworks. The discussion will address key legal and regulatory considerations, including anti-kickback statute compliance, manufacturer price reporting obligations, and 340B program eligibility and diversion concerns. Panelists will also review the challenges and opportunities of structuring value-based agreements that involve 340B entities, including unique issues that arise when hospital/health systems and their outpatient pharmacies participate in such models. Finally, the panel will discuss recent enforcement trends, manufacturer policies impacting 340B contract pharmacies, and legislative and policy developments that may impact 340B stakeholders engaged in value-based care initiatives. Special attention will be given to innovative contracting models between hospital/health systems and employer-sponsored health plans that incorporate 340B pricing as part of broader value-based care efforts.
| Certification Body | Credits | Type |
|---|---|---|
| BACB | 1 | General |
Dig into the research behind this topic — plain-English summaries written for BCBAs.
233 research articles with practitioner takeaways
165 research articles with practitioner takeaways
150 research articles with practitioner takeaways
You earn CEUs from a dozen different places. Upload any certificate — from here, your employer, conferences, wherever — and always know exactly where you stand. Learning, Ethics, Supervision, all handled.
No credit card required. Cancel anytime.
All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.